ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The US Pharmacopeia has approved new testing guidelines for sterile pharmaceutical products. Injected and implanted products must be free from bacterial endotoxins, which can cause inflammation. Widely used current tests rely on reagents extracted from wild horseshoe crabs, a practice that environmentalists say strains ecosystems. Synthetic alternatives have been approved in several countries, but US drug makers have been reluctant to change testing processes without a regulatory green light. The new guidelines will take effect in May 2025.
This story was updated on Sept. 24, 2024, to correct an error in the caption. Horseshoe crabs are the source of a key ingredient in endotoxin tests, not sterility tests.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter